BACKGROUND: Mechanistic models, when combined with pertinent data, can improve our knowledge regarding important molecular and cellular mechanisms found in cancer. These models make the prediction of tissue-level response to drug treatment possible, which can lead to new therapies and improved patient outcomes. Here we present a data-driven multiscale modeling framework to study molecular interactions between cancer, stromal, and immune cells found in the tumor microenvironment. We also develop methods to use molecular data available in The Cancer Genome Atlas to generate sample-specific models of cancer. RESULTS: By combining published models of different cells relevant to pancreatic ductal adenocarcinoma (PDAC), we built an agent-based mo...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
BACKGROUND: Mechanistic models, when combined with pertinent data, can improve our knowledge regardi...
BACKGROUND: Mechanistic models, when combined with pertinent data, can improve our knowledge regardi...
Pancreatic Ductal Adenocarcinoma (PDAC) is widely known for its poor prognosis because it is often d...
The ability to faithfully model complex processes lies at the heart of experimental biology. Althoug...
Pancreatic cancer represents one of the difficult problems of contemporary medicine. The development...
Background: Recent cancer studies revealed, the interaction between pancreatic cancer cells and panc...
Background: Recent cancer studies revealed, the interaction between pancreatic cancer cells and panc...
Cancer can be conceptualized as arising from somatic mutations resulting in a single renegade cell e...
Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year surviv...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies all over the world. T...
none8siPancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer dea...
Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of approximately 10% and is ex...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
BACKGROUND: Mechanistic models, when combined with pertinent data, can improve our knowledge regardi...
BACKGROUND: Mechanistic models, when combined with pertinent data, can improve our knowledge regardi...
Pancreatic Ductal Adenocarcinoma (PDAC) is widely known for its poor prognosis because it is often d...
The ability to faithfully model complex processes lies at the heart of experimental biology. Althoug...
Pancreatic cancer represents one of the difficult problems of contemporary medicine. The development...
Background: Recent cancer studies revealed, the interaction between pancreatic cancer cells and panc...
Background: Recent cancer studies revealed, the interaction between pancreatic cancer cells and panc...
Cancer can be conceptualized as arising from somatic mutations resulting in a single renegade cell e...
Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year surviv...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies all over the world. T...
none8siPancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer dea...
Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of approximately 10% and is ex...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...